From: Synthesizing evidence from clinical trials with dynamic interactive argument trees
Participants | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | SUS |
---|---|---|---|---|---|---|---|---|---|---|---|
p1 | 3 | 1 | 5 | 1 | 4 | 1 | 5 | 1 | 5 | 1 | 92.50 |
p2 | 4 | 1 | 5 | 2 | 5 | 1 | 5 | 1 | 4 | 1 | 92.50 |
p3 | 4 | 1 | 5 | 1 | 5 | 2 | 5 | 1 | 5 | 1 | 95.00 |
p4 | 4 | 3 | 3 | 1 | 3 | 3 | 5 | 2 | 4 | 1 | 72.50 |
p5 | 3 | 1 | 4 | 1 | 5 | 2 | 5 | 1 | 3 | 1 | 85.00 |
p6 | 4 | 1 | 5 | 1 | 4 | 2 | 5 | 2 | 4 | 1 | 87.50 |
p7 | 3 | 3 | 3 | 2 | 3 | 4 | 4 | 3 | 3 | 4 | 50.00 |
p8 | 5 | 1 | 5 | 1 | 4 | 1 | 5 | 1 | 4 | 1 | 95.00 |
p9 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | 3 | 57.50 |
p10 | 3 | 2 | 3 | 2 | 4 | 3 | 3 | 3 | 4 | 2 | 62.50 |
p11 | 3 | 2 | 4 | 2 | 4 | 2 | 4 | 2 | 3 | 2 | 70.00 |
p12 | 3 | 1 | 5 | 1 | 4 | 2 | 5 | 1 | 5 | 1 | 90.00 |
p13 | 2 | 3 | 4 | 1 | 4 | 3 | 4 | 2 | 4 | 2 | 67.50 |
p14 | 4 | 2 | 4 | 1 | 4 | 2 | 4 | 1 | 3 | 3 | 75.00 |
p15 | 3 | 1 | 5 | 1 | 2 | 2 | 5 | 1 | 5 | 1 | 85.00 |
p16 | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 2 | 4 | 2 | 65.00 |
p17 | 4 | 2 | 4 | 3 | 4 | 3 | 4 | 2 | 3 | 3 | 65.00 |
Average SUS | 76.91 |